The Cooper Companies, Inc.

The Cooper Companies, Inc. develops, manufactures, and markets contact lenses and women's health products. It operates through two segments: CooperVision and CooperSurgical. CooperVision offers a range of contact lenses including spherical, toric, and multifocal lenses that address vision challenges such as astigmatism, presbyopia, and myopia. CooperSurgical focuses on family and women's healthcare, providing fertility products and services, medical devices, contraception (including Paragard, a hormone-free intrauterine device), and cryostorage services such as cord blood and cord tissue storage. The company also offers donor gamete services and genomic services including genetic testing.

The Cooper Companies is listed on the Nasdaq Global Select Market (NasdaqGS) under the ticker symbol COO. Its shares are traded in US Dollars (USD). The company is headquartered in San Ramon, California, United States, and its primary listing is on the Nasdaq exchange in the US market.

The Cooper Companies operates in the Healthcare sector, specifically within the Medical Instruments & Supplies industry. This means the company is involved in the development, manufacturing, and marketing of medical devices and supplies used in healthcare settings. Its products include contact lenses for vision correction and a range of women's health and fertility products, which fall under the broader medical instruments and supplies category.

The Cooper Companies is headquartered in San Ramon, California, United States. The company was founded in 1958. It serves a global market, selling its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. Its two main segments, CooperVision and CooperSurgical, address vision correction and women's health needs respectively, reaching customers worldwide.

The Cooper Companies generates revenue through two main segments: CooperVision and CooperSurgical. CooperVision sells spherical, toric, and multifocal contact lenses to eye care professionals and retailers, addressing vision challenges like astigmatism, presbyopia, and myopia. CooperSurgical generates revenue from fertility products and services, medical devices, contraception (including Paragard IUD), and cryostorage services such as cord blood and tissue storage. Additionally, it offers donor gamete services and genomic testing. The company sells through distributors, group purchasing organizations, and directly to healthcare professionals and institutions.